Istari Oncology Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Istari Oncology

Access the complete profile.

Istari Oncology Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325414 Biological Product Manufacturing
Address	6 Davis Dr Durham, NC 27709

Note: Revenues for privately held companies are statistical evaluations.


Istari Oncology's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Istari Oncology's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Istari Oncology is classified as operating in the Biological Product Manufacturing industry, NAICS Code 325414.

Istari Oncology Annual Revenue and Growth Rate

Istari Oncology	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Istari Oncology's revenues are gauged from an analysis of company filings.

Istari Oncology's Income Statement (based on Industry Averages)

Istari Oncology P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Istari Oncology has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
April 20, 2021	17	62%	$70 MM
Complete list of funding rounds and total amounts in the Company Report

Market Share of Istari Oncology's Largest Competitors

A competitive analysis shows these companies are in the same general field as Istari Oncology, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
OXFORD BIOMEDICA SOLUTIONS	Bedford, MA	100
LAMPIRE BIOLOGICAL LABS	Pipersville, PA	85
MG BIOLOGICS	Ames, IA	39
BIO-SYNTHESIS	Lewisville, TX	37
GREEN MOUNTAIN ANTIBODIES	Burlington, VT	34
TRANS-INDIA PRODUCTS	Santa Rosa, CA	28
PMA MEDIA GROUP	Lehi, UT	25
BAILEY BARK MATERIALS	Nacogdoches, TX	24
1GLOBE HEALTH INSTITUTE	Norwood, MA	23

Nearby Competitors

These companies are similar in business line and location to Istari Oncology. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
TERGUS PHARMA	Durham, NC	100
HUMACYTE GLOBAL	Durham, NC	87
MEDICAGO USA	Durham, NC	67
BRII BIOSCIENCES	Durham, NC	51
FENNEC PHARMACEUTICALS	Research Triangle Park, NC	46
DOVA PHARMACEUTICALS	Durham, NC	42

Future Competition: Istari Oncology's Fastest Growing Competitors

These companies are in the same general field as Istari Oncology and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)